Lung-MAP master protocol model broadens trial

As compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cancer Master Protocol (Lung-MAP) has enrolled higher percentages of patients who are older, patients who are from rural or socioeconomically deprived areas, and patients who have Medicaid or no insurance.

Related Keywords

Oregon ,United States ,Katherine Minichiello ,Jyotid Patel ,Maryw Redman ,Lu Qian ,Michaell Leblanc ,Joelw Neal ,Karen Kelly ,Ellenv Sigal ,Staceyj Adam ,Riha Vaidya ,Josephm Unger ,Roys Herbst ,Saiaman Waqar ,Konstantinh Dragnev ,Martinj Edelman ,Charlesd Blanke ,Shakun Malik ,Jhanellee Gray ,Davidr Gandara ,Stanford Cancer Institute ,Friends Of Cancer Research ,Oregon Health ,Amgen ,Northwestern University Feinberg School Of Medicine ,Fred Hutchinson Cancer Center ,Temple University Health System ,Moffitt Cancer Center ,Community Oncology Research Program ,Foundation Medicine ,Data Management Center ,Winship Cancer Institute ,National Cancer Institute Clinical Trials Network ,Emory University ,Pfizer ,Fox Chase Cancer Center ,Twitter ,Cancer Research Network ,National Cancer Institute ,Foundation For The National Institutes Of Health ,Astrazeneca ,Science University ,Genentech ,Method Of Research ,Uc Davis Comprehensive Cancer Center ,Yale Cancer Center ,National Institutes Of Health ,Dartmouth Cancer Center ,Bristol Myers Squibb ,National Clinical Trials Network ,Washington University School Of Medicine ,Lung Cancer Master Protocol ,National Clinical Trials ,National Institutes ,Research Network ,Cancer Research ,Area Deprivation Index ,Comprehensive Cancer Center ,Northwestern University Feinberg School ,Washington University School ,Fred Hutchinson Cancer ,Patients Enrolled ,Oncology Research Program ,